You are here: All Products  > Alphamab to Start US Phase I Clinical Trial of HER2 Bispecific Antibody

Alphamab to Start US Phase I Clinical Trial of HER2 Bispecific Antibody

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products